Evaluation of Diagnostic Efficiency of PIVKA-II and Other Tumor Markers in HCC
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Study of Apatinib in Advanced Hepatocellular Carcinoma(HCC)
- Status
- UNKNOWN
- Phase
- PHASE2
Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Liver Cancer Receiving Transarterial Chemoembolization With Drug Eluting Beads
- Status
- COMPLETED
- Phase
- PHASE1
Long-term Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based Treatment
- Status
- UNKNOWN
- Phase
- N/A
Immunological Response After Ablative Therapy in the Liver
- Status
- WITHDRAWN
- Phase
- NA
Lipotecan Based Concurrent Chemoradiotherapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Y90-Radioembolization With Nivolumab in Asians With Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Statin for Preventing Hepatocellular Carcinoma Recurrence After Curative Treatment
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC with Major Portal Vein Tumor Thrombosis
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Drug Eluting Beads TACE in Treatment of HCC in Egyptian Patients
- Status
- COMPLETED
- Phase
- PHASE4
A Trial of Lenvatinib Plus Pembrolizumab in Participants With Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of Tocilizumab in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transarterial Chemoembolization (TACE)
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of Safety and Tolerability of PDR001 in Combination With Sorafenib and to Identify the Maximum Tolerated Dose and/or Phase 2 Dose for This Combination in Advanced Hepatocellular Patients
- Status
- COMPLETED
- Phase
- PHASE1
The Impact on Therapeutic Effect and Tolerance of Treatment for Patients With Hepatocellular Carcinoma in Transcatheter Arterial Chemoembolization (TACE) of Dexamethasone Application: A Random, Double-blind, Controlled, Clinical Trial.
- Status
- UNKNOWN
- Phase
- PHASE3
Phase II Study of HAIC Using Cisplatin,Leucovorin and 5-Fluorouracil
- Status
- UNKNOWN
- Phase
- PHASE2
Phase II Trial of Sorafenib Combined With Concurrent HAIC for Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
HAIC Versus TACE for Large Hepatocellular Carcinoma Staged BCLC A/B.
- Status
- COMPLETED
- Phase
- PHASE3
Proof of Concept Study Concerning Efficacy of P03277 MR Imaging in HCC Diagnosis
- Status
- COMPLETED
- Phase
- PHASE2
Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus
- Status
- UNKNOWN
- Phase
- PHASE3